Showing results (231-240 of 506) with videos related to
Sort By:
Pageof 51
Journal of Clinical Pathology|May 1, 1988
Amiloride prevents amphotericin B related hypokalaemia in neutropenic patientsS R Smith, M J Galloway, J T Reilly, et al.Cancer Treatment Reports|December 1, 1987
Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive diseaseM H Cullen, S R Smith, G F Benfield, et al.Journal of Personality Disorders|January 14, 2000
The clinical utility of the MMPI-2 Antisocial Practices Content ScaleS R Smith, M J Hilsenroth, F D Castlebury, et al.Cellular Immunology|November 1, 1996
Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethalityS R Smith, C Terminelli, G Denhardt, et al.Chest|May 1, 1982
Indications for mediastinal lymph node evaluationS R Smith, R G Hooper, C R Beechler, et al.Journal of Leukocyte Biology|June 1, 1994
The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemiaS R Smith, C Terminelli, L Kenworthy-Bott, et al.British Journal of Clinical Pharmacology|January 1, 1985
Reproducibility of oxprenolol plasma concentrations in young female volunteers following oral administration of an oxprenolol Oros dosage formD B Jack, M J Kendall, S J Laugher, et al.Biopharmaceutics & Drug Disposition|January 1, 1986
The pharmacokinetics of oral and intravenous prenalterol in young, healthy volunteersA F Clarke, D B Jack, M J Kendall, et al.The Journal of Bone and Joint Surgery. British Volume|March 1, 1994
Results of uncemented porous-coated anatomic total hip replacementT D Owen, C G Moran, S R Smith, et al.Journal of Clinical Pharmacy and Therapeutics|April 1, 1987
The pharmacokinetics of oxprenolol following oral and rectal dosing--a comparison of delivery systems and routes of administrationM R Gregg, D B Jack, S R Smith, et al.Pageof 51